Records containing: Malaria
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-11-25A Randomized, Double-blind, Placebo-controlled, Clinical Trial of a 3-dose, 28-day Regimen of PfSPZ Vaccine in Healthy, Adult Participants to Determine Safety, Tolerability and Efficacy Against Heterologous Plasmodium Falciparum Controlled Human Malaria Infection Conducted 3 or 12 Weeks After Immunization
-
CLINICAL_TRIALS study record update · 2024-11-20Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania
-
CLINICAL_TRIALS study record update · 2024-11-14Impact of Long-lasting Insecticidal Nets (LLINs) Treated With Pyrethroid Plus Pyriproxyfen vs LLINs Treated With Pyrethroid Plus Piperonyl Butoxide on Malaria Incidence in Uganda: a Cluster-randomised Trial
-
CLINICAL_TRIALS study record update · 2024-11-06An Open Label Phase I/IIa Clinical Trial to Assess the Safety, Immunogenicity and Efficacy of the Malaria Vaccine Candidate RH5.2-virus-like Particle (VLP) in Matrix-MTM, and to Compare the Safety and Immunogenicity of the Malaria Vaccine Candidates RH5.2-VLP in Matrix-MTM and RH5.1 Soluble Protein in Matrix-MTM Used in Various Regimens
-
CLINICAL_TRIALS study record update · 2024-10-29A Phase 2a, Multicenter, Open-label, Dose-finding, Dose Escalation Study of Meplazumab in Adult Patients Diagnosed with Uncomplicated Plasmodium Falciparum Malaria
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-10-24Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-prefecture, Guinea
-
CLINICAL_TRIALS study record update · 2024-10-24Antimalarial Pharmacology in HIV Infected and Uninfected Children and Pregnant Women in Uganda
-
CLINICAL_TRIALS study record update · 2024-10-18Efficacy of Two Dual Active Ingredient Long Lasting Insecticidal Nets for Control of Malaria Transmitted by Pyrethroid Resistant Vectors in Benin
-
CLINICAL_TRIALS study record update · 2024-10-17A Two-part, Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Single Doses of MMV533, Including a Pilot Food Evaluation in Healthy Participants.
-
CLINICAL_TRIALS study record update · 2024-10-04Phase I Clinical Trial to Assess the Safety and Immunogenicity of the Malaria Vaccine Candidate RH5.1 Soluble Protein in Matrix-MTM Using Two Dosing Regimens
-
CLINICAL_TRIALS study record update · 2024-10-01Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire: Research on Vector Control Strategies
-
CLINICAL_TRIALS study record update · 2024-10-01Evaluation of the Safety and Efficacy of Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment of Malaria in HIV-infected Pregnant Women
-
CLINICAL_TRIALS study record update · 2024-09-19A Prospective Study to Estimate the Incidence of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Infants and Young Children in Sub-Saharan Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
-
CLINICAL_TRIALS study record update · 2024-09-19Effectiveness of an Educational Intervention to Improve Knowledge, Attitudes and Practices for the Prevention of Malaria in the Embera Katio Population of the Department of Cordoba
-
CLINICAL_TRIALS study record update · 2024-08-29Seasonal R21 Mass Vaccination for Malaria Elimination
-
CLINICAL_TRIALS study record update · 2024-08-29Short Course Radical Cure of P.Vivax in Nepal- a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-08-27A Prospective Surveillance Study to Detect Antimalarial Drug Resistance, Gene Deletions of Diagnostic Relevance and Genetic Diversity of Plasmodium Falciparum in Mozambique
-
CLINICAL_TRIALS study record update · 2024-08-26Plasmodium Falciparum Molecular Surveillance in Mozambique to Monitor Markers of Antimalarial Drug Resistance, Rapid Tests Diagnostic Failure and Transmission in Mozambique: Phase 2
-
CLINICAL_TRIALS study record update · 2024-08-19Evaluation of a Comprehensive School Health Programme in Zambia: a Cluster-randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-07-25A Cluster Randomized Controlled Trial of Pro-active Community Case Management for Malaria in Chadiza District, Eastern Province, Zambia
-
CLINICAL_TRIALS study record update · 2024-07-11Phase 2 Proof of Concept Study of a Candidate Aminoquinoline Antimalarial (AQ-13)
-
CLINICAL_TRIALS study record update · 2024-07-10Safety and Efficacy of L9LS, a Human Monoclonal Antibody Against Plasmodium Falciparum, in a Dose-Escalation Trial in Adults and Children and a Randomized, Double-Blind Trial of Children in Mali
-
CLINICAL_TRIALS study record update · 2024-06-26Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study
-
CLINICAL_TRIALS study record update · 2024-06-24Mass Drug Administration With Dihydroartemisinin-piperaquine and Primaquine to Reduce Malaria in a Moderate-low Transmission Setting in Senegal: A Cluster Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-06-21Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in Children ≤ 5 Years of Age in Uganda: Study Protocol for a Cluster-randomized Double-blinded Control Trial: The Mossie-GO Trial